scholarly journals A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression

2013 ◽  
Vol 70 (1) ◽  
pp. 31 ◽  
Author(s):  
Charles L. Raison ◽  
Robin E. Rutherford ◽  
Bobbi J. Woolwine ◽  
Chen Shuo ◽  
Pamela Schettler ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Tumor Necrosis ◽  
Controlled Trial ◽  
Treatment Resistant Depression ◽  
Treatment Resistant ◽  
Tumor Necrosis Factor Antagonist ◽  
Randomized Controlled ◽  
Resistant Depression ◽  
Factor Antagonist ◽  
Necrosis Factor

scholarly journals Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial

2019 ◽  
Vol 176 (5) ◽  
pp. 401-409 ◽  
Author(s):  
Jennifer L. Phillips ◽  
Sandhaya Norris ◽  
Jeanne Talbot ◽  
Meagan Birmingham ◽  
Taylor Hatchard ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Treatment Resistant Depression ◽  
Treatment Resistant ◽  
Randomized Controlled ◽  
Resistant Depression

scholarly journals Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Sanne Y. Smith-Apeldoorn ◽  
Jolien K. E. Veraart ◽  
Jeanine Kamphuis ◽  
Antoinette D. I. van Asselt ◽  
Daan J. Touw ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Treatment Resistant Depression ◽  
Treatment Resistant ◽  
Randomized Controlled ◽  
Resistant Depression

After publication of our article [1] we were notified that Figure 1 was wrongly presented.

Sign in / Sign up

Export Citation Format

Share Document